IL184944A0 - Process for the preparation of anticancer drugs - Google Patents

Process for the preparation of anticancer drugs

Info

Publication number
IL184944A0
IL184944A0 IL184944A IL18494407A IL184944A0 IL 184944 A0 IL184944 A0 IL 184944A0 IL 184944 A IL184944 A IL 184944A IL 18494407 A IL18494407 A IL 18494407A IL 184944 A0 IL184944 A0 IL 184944A0
Authority
IL
Israel
Prior art keywords
preparation
anticancer drugs
anticancer
drugs
Prior art date
Application number
IL184944A
Other languages
English (en)
Original Assignee
Sicor Inc
Villa Marco
Diulgheroff Nicola
Fretta Roberto
Pontiroli Alessandro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Inc, Villa Marco, Diulgheroff Nicola, Fretta Roberto, Pontiroli Alessandro filed Critical Sicor Inc
Publication of IL184944A0 publication Critical patent/IL184944A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL184944A 2005-04-06 2007-07-31 Process for the preparation of anticancer drugs IL184944A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66913205P 2005-04-06 2005-04-06
US69452805P 2005-06-27 2005-06-27
PCT/US2006/013140 WO2006108155A2 (en) 2005-04-06 2006-04-06 Process for the preparation of anastrozole

Publications (1)

Publication Number Publication Date
IL184944A0 true IL184944A0 (en) 2007-12-03

Family

ID=36694325

Family Applications (1)

Application Number Title Priority Date Filing Date
IL184944A IL184944A0 (en) 2005-04-06 2007-07-31 Process for the preparation of anticancer drugs

Country Status (8)

Country Link
US (2) US7692025B2 (enExample)
EP (2) EP1751121A2 (enExample)
JP (1) JP2008536836A (enExample)
KR (1) KR20080000621A (enExample)
CA (1) CA2601649A1 (enExample)
IL (1) IL184944A0 (enExample)
MX (1) MX2007012394A (enExample)
WO (1) WO2006108155A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2601649A1 (en) 2005-04-06 2006-10-12 Sicor Inc. Process for the preparation of anastrozole
AR061016A1 (es) * 2006-05-19 2008-07-30 Synthon Bv Proceso para la purificacion de anastrozol
US8058302B2 (en) * 2006-06-05 2011-11-15 Cadila Healthcare Limited Process for preparing pure anastrozole
US7989636B2 (en) * 2006-10-17 2011-08-02 Cipla Limited Process for the preparation of pure anastrozole
WO2009010991A2 (en) * 2007-07-17 2009-01-22 Ind-Swift Laboratories Limited Purification process to prepare highly pure anastrozole
EP2343278A1 (en) 2010-01-07 2011-07-13 Hexal AG A process for preparing trisubstituted phenyl derivatives comprising a (1H-1,2,4-triazol-1-yl)alkyl group
CN106083748B (zh) * 2016-06-21 2019-08-16 扬子江药业集团江苏海慈生物药业有限公司 一种阿那曲唑的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714013D0 (en) * 1987-06-16 1987-07-22 Ici Plc (substituted-aralkyl)heterocyclic compounds
JPH07138234A (ja) * 1993-11-11 1995-05-30 Kureha Chem Ind Co Ltd アゾリルメチルシクロアルカノール誘導体の製造方法
EP1165512A2 (de) * 1999-03-30 2002-01-02 Gödecke Gmbh Verfahren zur herstellung von n-aryl-aza-heterocyclen in gegenwart von cesiumcarbonat
US8436029B2 (en) 2004-03-19 2013-05-07 Transform Pharmaceuticals, Inc. Pharmaceutical forms, and methods of making and using the same
WO2005105762A1 (en) * 2004-05-05 2005-11-10 Natco Pharma Limited Improved process for the preparation of high purity anastrozole
GB0412492D0 (en) 2004-06-04 2004-07-07 Sterix Ltd Compound
DE102005037484A1 (de) * 2004-08-09 2006-02-23 Chemagis Ltd. Neue Verfahren zur Herstellung von im Wesentlichen reinem Anastrozol
US20060189670A1 (en) 2005-02-22 2006-08-24 Glenmark Pharmaceuticals Limited Process for the preparation of anastrozole and intermediates thereof
EP1705168A1 (en) * 2005-03-21 2006-09-27 Helm AG Improved process for side-chain bromination of alkyl-benzenes
CA2601649A1 (en) * 2005-04-06 2006-10-12 Sicor Inc. Process for the preparation of anastrozole
WO2007002722A2 (en) 2005-06-27 2007-01-04 Sicor, Inc. Synthesis of anastrozole and purification of one of its intermediate
US20090221837A1 (en) 2005-09-30 2009-09-03 Kirtipalsinh Saijansinh Solanki Process for the Preparation of Pure Anastrozole
WO2007039913A1 (en) * 2005-10-05 2007-04-12 Usv Limited Process for the preparation of 2,2’-[5-(1,2,4-triazole-1-ylmethyl) -1,3-phenylene] di (2-methylpropionitrile).
WO2007039919A1 (en) 2005-10-06 2007-04-12 Natco Pharma Limited Crystalline forms of anastrozole
US20070100148A1 (en) 2005-10-31 2007-05-03 Veerender Murki Process for preparing anastrozole
WO2007105231A1 (en) 2006-03-10 2007-09-20 Shilpa Medicare Ltd. Improved process for high purity anastrozole
AR061016A1 (es) * 2006-05-19 2008-07-30 Synthon Bv Proceso para la purificacion de anastrozol
US8058302B2 (en) 2006-06-05 2011-11-15 Cadila Healthcare Limited Process for preparing pure anastrozole
FR2904821B1 (fr) 2006-08-09 2009-02-20 Air Liquide Procede de purification d'hydrogene
WO2008034644A2 (en) 2006-09-22 2008-03-27 Synthon B.V. Process for making anastrozole
US7989636B2 (en) 2006-10-17 2011-08-02 Cipla Limited Process for the preparation of pure anastrozole
US20080177081A1 (en) * 2007-01-19 2008-07-24 Formosa Laboratories, Inc. Process for Preparation of Anastrozole

Also Published As

Publication number Publication date
MX2007012394A (es) 2007-11-07
US7692025B2 (en) 2010-04-06
CA2601649A1 (en) 2006-10-12
WO2006108155A2 (en) 2006-10-12
EP2172449A3 (en) 2011-06-22
KR20080000621A (ko) 2008-01-02
EP1751121A2 (en) 2007-02-14
JP2008536836A (ja) 2008-09-11
WO2006108155A3 (en) 2006-11-23
US20060276657A1 (en) 2006-12-07
EP2172449A2 (en) 2010-04-07
US20100099888A1 (en) 2010-04-22

Similar Documents

Publication Publication Date Title
IL188330A0 (en) Processes for the preparation of
TWI449540B (en) Process for the production of an abuse-proofed dosage form
DK3872058T3 (en) Process for the preparation of 2,3,3,3 tetrahydrofluoropropene
IL185972A0 (en) Process for the preparation of opioid modulators
IL194961A0 (en) Compounds a-r-x for the manufacture of pharmaceutical preparations
PL2096937T3 (pl) Sposób wytwarzania produktów herbacianych o zwiększonej zawartości teaflawiny
IL190666A0 (en) Process for the preparation of insulin conjugates
ZA200804264B (en) Process for the preparation of ferri-succinylcasein
PL1844036T3 (pl) Sposób otrzymywania arypiprazolu
IL213474A0 (en) Processes for the preparation of cyclopropyl-amide derivatives
ZA200601910B (en) Process for the preparation of organosilances
IL187658A0 (en) Process for the preparation of 3,7-dihydroxy-1,5-diazacyclooctanes
EP1996192A4 (en) PROCESS FOR PREPARING 3,4-SUBSTITUTED THIAZOLIDIN-2-ONES IN 3,4
ZA200710664B (en) Processes for the preparation of docetaxel
IL187855A0 (en) Processes for the preparation of docetaxel
GB2461667B (en) 4¼-amino podophyllotoxin congeners as potential anticancer agents and a process for the preparation thereof
HUP0401379A3 (en) Process for the preparation of risperidon
PL1928883T3 (pl) Sposób otrzymywania chlorowodorku irynotekanu
GB0816068D0 (en) Process for the preparation of explosive particles
HU0500570D0 (en) Process for the preparation of (s)-(-)-amlodipine
EP1915380A4 (en) PROCESS FOR THE SYNTHESIS OF N, N'-DISUBSTITUTED OXABISPIDINES
IL197408A0 (en) Process for the preparation of abacavir
AP2438A (en) Pharmaceutical composition suitable for the treatment of malaria within one day
ZA200802108B (en) Pharmaceutical composition suitable for the treatment of malaria within one day
SI1732916T1 (sl) Postopek za pripravo alkoksikarbonilmetoksi-ciklopentanov